Health and Me

Rachel V Thomas

UK Woman Spends £4,000 On Wegovy, Mounjaro, But Loses Less Than 14 Pounds In 15 Months

A UK woman has claimed that <span>Wegovy</span> and <span>Mounjaro</span>, the blockbuster GLP-1 weight-loss drugs from <span>Novo Nordisk</span> and <span>Eli Lilly</span>, did not help her lose much weight despite more than a year of treatment.

Karen Lay, 56, from Essex, spent £4,000 on the medications, hoping they would help her slim down from 16 stone (224 pounds). However, after 15 months, she lost less than a stone, despite eating very little.

Lay now says the injections were far from a "magic fix" and credits a structured diet for helping her lose two stone, <em>the Daily Mail</em> reported.

<h2>Started Wegovy, Mounjaro Out of 'Sheer Desperation'</h2>

Lay began taking Wegovy in late 2023 after trying several diets without success. She remained on the medication for nine months, even though she felt something "wasn't right."

“My appetite reduced slightly at first,” Lay, a financial services worker, was quoted as saying. “But not enough to make a meaningful difference, so I increased the dosage each month.” 

After seeing limited results with Wegovy, Lay stopped the medication for four weeks before switching to Mounjaro. She described the transition period as experiencing the "worst food noise" and said she gained more than seven pounds while waiting for the first drug to clear from her system.

Lay then spent six months on Mounjaro but said she was "barely eating" and still failed to achieve the weight loss she expected.

“I only lost seven pounds,” she said. “I realised the injections simply weren't effective for me and something had to change.”

Her doctor eventually advised her to stop taking the medication because they were concerned she was not eating enough, the report said. 

Lay said the experience was “emotionally exhausting and honestly quite soul-destroying,” and "deeply disheartening.” Watching others succeed on the drugs made it even harder.

After discontinuing the injections, Lay adopted a very low-calorie diet with support from expert nutrition advisers who provided personalized guidance.

“Once the medication was fully out of my system, I began to feel genuinely better,” Lay said, adding that her “energy returned, digestion improved, and the constipation disappeared.”

Within a year, she went from a dress size 18 to size 12, the smallest she had been in 17 years, with her weight falling to 13 stone 5 pounds, the report said.

Clinical trials have shown that most people taking these medications experience substantial weight loss.

<ul><li>Wegovy: Average weight loss of about 21% after 72 weeks.</li><li>Mounjaro: Average weight loss of about 22.5% over a similar period.</li></ul>

Around 2.5 million adults in the UK are estimated to be using weight-loss injections, while hundreds of thousands have signed up for the newly approved Wegovy pill, which was rolled out by the NHS this month.

But some people are 'non-responders', meaning they do not lose a meaningful amount of weight despite treatment. Research earlier this year found that around one in 10 people taking GLP-1 medications are considered non-responders.

<h2>Why Weight-Loss Drugs May Not Work For All</h2>

Although GLP-1 receptor agonists have delivered remarkable results for many people, they do not work the same way for everyone. Obesity is a complex condition influenced by brain signaling, hormones, genetics, and metabolism, meaning treatment responses can vary significantly. Possible reasons include:

<ul><li>Genetic and hormonal variability</li><li>Underlying medical conditions</li><li>Unrealistic expectations about weight-loss outcomes</li></ul>When medications such as Wegovy or Ozempic do not produce the desired results, other options may include:

<ul><li>Switching to another GLP-1 medication</li><li>Using older, approved weight-loss medications</li><li>Structured lifestyle changes involving diet and physical activity</li><li>Comprehensive medical management of obesity tailored to the individual.</li></ul>

Health Conditions A-Z

health

uk-woman-spends-4000-on-wegovy-mounjaro-but-loses-less-than-14-pounds-in-15-months

Wegovy

Novo Nordisk

Eli Lilly

glp 1 drugs

mounjaro

GLP 1 weight loss drugs

donald-trump-urges-rfk-jr-to-accelerate-childhood-vaccine-rollback

Donald Trump Urges RFK Jr. To Accelerate Childhood Vaccine Rollback

nearly-33-adults-in-us-may-need-blood-pressure-medication-yet-most-go-untreated

Nearly 33% Adults In US May Need Blood Pressure Medication, Yet Most Go Untreated

Health & Wellness

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

A UK woman has claimed that Wegovy and Mounjaro, the blockbuster GLP-1 weight-loss drugs from Novo Nordisk and Eli Lilly, did not help her lose much weight despite more than a year of treatment.Karen Lay, 56, from Essex, spent £4,000 on the medications, hoping they would help her slim down from 16 stone (224 pounds). However, after 15 months, she lost less than a stone, despite eating very little.Lay now says the injections were far from a "magic fix" and credits a structured diet for helping her lose two stone, the Daily Mail reported.Started Wegovy, Mounjaro Out of 'Sheer Desperation'Lay began taking Wegovy in late 2023 after trying several diets without success. She remained on the medication for nine months, even though she felt something "wasn't right."“My appetite reduced slightly at first,” Lay, a financial services worker, was quoted as saying. “But not enough to make a meaningful difference, so I increased the dosage each month.” After seeing limited results with Wegovy, Lay stopped the medication for four weeks before switching to Mounjaro. She described the transition period as experiencing the "worst food noise" and said she gained more than seven pounds while waiting for the first drug to clear from her system.Lay then spent six months on Mounjaro but said she was "barely eating" and still failed to achieve the weight loss she expected.“I only lost seven pounds,” she said. “I realised the injections simply weren't effective for me and something had to change.”Her doctor eventually advised her to stop taking the medication because they were concerned she was not eating enough, the report said. Lay said the experience was “emotionally exhausting and honestly quite soul-destroying,” and "deeply disheartening.” Watching others succeed on the drugs made it even harder.Switched to Diet InsteadAfter discontinuing the injections, Lay adopted a very low-calorie diet with support from expert nutrition advisers who provided personalized guidance.“Once the medication was fully out of my system, I began to feel genuinely better,” Lay said, adding that her “energy returned, digestion improved, and the constipation disappeared.”Within a year, she went from a dress size 18 to size 12, the smallest she had been in 17 years, with her weight falling to 13 stone 5 pounds, the report said.Non-responders To GLP-1 DrugsClinical trials have shown that most people taking these medications experience substantial weight loss.Wegovy: Average weight loss of about 21% after 72 weeks.Mounjaro: Average weight loss of about 22.5% over a similar period.Around 2.5 million adults in the UK are estimated to be using weight-loss injections, while hundreds of thousands have signed up for the newly approved Wegovy pill, which was rolled out by the NHS this month.But some people are 'non-responders', meaning they do not lose a meaningful amount of weight despite treatment. Research earlier this year found that around one in 10 people taking GLP-1 medications are considered non-responders.Why Weight-Loss Drugs May Not Work For AllAlthough GLP-1 receptor agonists have delivered remarkable results for many people, they do not work the same way for everyone. Obesity is a complex condition influenced by brain signaling, hormones, genetics, and metabolism, meaning treatment responses can vary significantly. Possible reasons include:Genetic and hormonal variabilityUnderlying medical conditionsUnrealistic expectations about weight-loss outcomesWhen medications such as Wegovy or Ozempic do not produce the desired results, other options may include:Switching to another GLP-1 medicationUsing older, approved weight-loss medicationsStructured lifestyle changes involving diet and physical activityComprehensive medical management of obesity tailored to the individual.

uk woman spends £4,000 on wegovy, mounjaro, but loses less than 14 pounds in 15 months

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

UK Woman Spends £4,000 On Wegovy, Mounjaro, But Loses Less Than 14 Pounds In 15 Months

World ORS Day: The Life-Saving Drink Every Home Should Have

From Hepatitis To Cirrhosis: Understanding The Long-Term Risks Of Delayed Treatment

Smoking, Diabetes, High Blood Pressure May Fuel the Most Dangerous Type of Artery Plaque, Study Finds

Health Conditions A-Z

UK Woman Spends £4,000 On Wegovy, Mounjaro, But Loses Less Than 14 Pounds In 15 Months

Donald Trump Urges RFK Jr. To Accelerate Childhood Vaccine Rollback

Nearly 33% Adults In US May Need Blood Pressure Medication, Yet Most Go Untreated